Clinical Trials Logo

Filter by:
NCT ID: NCT06368843 Not yet recruiting - Clinical trials for Postoperative Sore Throat

the Impact of Ketamine Gargling on the Incidence of Post Intubation Sore Throat

Start date: April 25, 2024
Phase:
Study type: Observational

Tracheal intubation often causes trauma to the airway mucosa, leading to postoperative sore throat (POST), which has been reported to occur in 21-65% of cases. While considered a minor complication, POST can contribute to postoperative discomfort and patient dissatisfaction.

NCT ID: NCT06371196 Not yet recruiting - Clinical trials for Primary Biliary Cholangitis

Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule

Start date: April 25, 2024
Phase: Phase 4
Study type: Interventional

1. Explore the effect of Babaodan Capsule on the serum total bilirubin level of primary biliary cholangitis patients with elevated total serum bilirubin; 2. To observe the positive intervention effect of Babaodan Capsule on the clinical symptoms of primary biliary cholangitis patients with elevated total bilirubin.

NCT ID: NCT06371560 Not yet recruiting - Periodontitis Clinical Trials

Antibiotics, Antibiotic Resistance, and Prescribing Practices Among Periodontists: Cross Sectional KAP Study

Start date: April 25, 2024
Phase:
Study type: Observational

Antibiotic resistance is a global health threats that require attention from all healthcare providers. In Periodontology, antibiotic is prescribed in many clinical situations. The aim of this study is to assess the followings among Periodontists (1) The knowledge, attitude, and practices (KAP) towards antibiotics and antibiotic resistance; (2) The prescribing practices of antibiotics in periodontal therapy; (3) The correlation between personal perception of antibiotics uses and the professional prescription patterns; and (4) The differences in antibiotics prescription in relation to the years of experience and the academic background.

NCT ID: NCT06374901 Not yet recruiting - Gastric Cancer Clinical Trials

Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.

Start date: April 25, 2024
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy of Tislelizumab in combination with chemotherapy versus chemotherapy in neoadjuvant treatment of patients with MHC-II positive (IHC≥2+) and locally advanced gastric/gastroesophageal junction adenocarcinoma by evaluating the main pathologic response rate (MPR).

NCT ID: NCT06376019 Not yet recruiting - Edentulous Jaw Clinical Trials

Occlusion and Disocclusion Time in Immediately Loaded Overdentures Supported by Two Splinted Versus Non Splinted Interforaminal Implants

Start date: April 25, 2024
Phase: N/A
Study type: Interventional

complete denture wearers struggle to eat well with their dentures due to poor denture retention, stability, and occlusal disharmony. So, the current study protocol aims to compare the occlusion/ disocclusion time in immediately loaded implant retained overdentures supported by two interforaminal implants; splinted versus non splinted dental implants compared to the conventional complete denture.

NCT ID: NCT06376617 Not yet recruiting - Bronchial Asthma Clinical Trials

Pattern Of Isolated Fungi From Bronchoalveolar Lavage Among Patients With Bronchial Asthma

Start date: April 25, 2024
Phase: N/A
Study type: Interventional

This study is to assess the pattern of isolated fungi from the respiratory air way (bronchial tree) from bronchoalvealar lavage (BAL) in asthmatic patients with uncontrolled or difficult to treat asthma

NCT ID: NCT06377670 Not yet recruiting - Clinical trials for Wassel IV Thumb Duplication

Study of Functional and Aesthetic Outcomes After Wassel IV Thumb Duplication Surgery in Pediatric Population, With a Follow-up of at Least One Year

Start date: April 25, 2024
Phase:
Study type: Observational

The purpose of this study is to evaluate the functional and aesthetic outcomes in children with Wassel IV thumb duplication

NCT ID: NCT06378138 Not yet recruiting - Clinical trials for Hematologic Malignancies

ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Start date: April 25, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

Evaluate the safety, tolerability and pharmacokinetics of ICP-248 in Combination with Orelabrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT ID: NCT06380582 Not yet recruiting - Clinical trials for Cognitive Performance

Indoor Air Quality, Temperature and Cognitive Performance

AEOLUS
Start date: April 25, 2024
Phase: N/A
Study type: Interventional

Study design: A cross-over single-blinded treatment design will be used. Participants will undergo 4 different conditions: (1) low air flow and 23°C, (2) low air flow and 35°C, (3) high air flow and 23°C, and (4) high air flow and 35°C. Participants will be blinded to the air quality level; however, it is not possible to blind them to the temperature condition, as they will be able to perceive it as different. Study population: The population consists of healthy young and middle-aged adults of both sexes between 18 and 40 years. Intervention (if applicable): Each participant undergoes 4 conditions in randomized order. Two conditions consist of poor air quality defined as 3,000 ppm carbon dioxide and 23°C or 35°C temperature, respectively.

NCT ID: NCT06384235 Not yet recruiting - Clinical trials for Locally Advanced or Metastatic CRC

Phase II Clinical Study of LTC004 in Patients With mCRC

Start date: April 25, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This is a phase II clinical study to evaluate the safety and antitumor activity of LTC004 in patients with locally advanced or metastatic CRC,Enrollment of 10 evaluable subjects in Phase I. If ≥2 subjects experience objective remission,proceed to Phase II to enroll an additional 20 evaluable subjects to further evaluation of the safety and efficacy of LTC004